NCT05459168

Brief Summary

Using the IDEAS (Integrate, Design, Assess, and Share) framework, the investigators will conduct the following aims: Specific Aim 1: Using two focus groups, the investigators will INTEGRATE formative work, the social cognitive theory, and perspectives from the experienced-user advisory committee (N=20) who will use the current Calm platform to identify design content and features for a standalone cancer-specific app prototype leveraging the commercial infrastructure of the Calm platform. The advisory committee will consist of both cancer patients/survivors (n=10; 5 of each) and health care providers (n=10). Specific Aim 2: DESIGN a meditation app prototype tailored to cancer patients/survivors unique needs including content related to cancer-related experiences, emotions, symptoms, physical and psychological needs, cancer-specific symptom self monitoring, social support and sense of belonging within the app and through Facebook. Specific Aim 3: ASSESS (i.e., beta-test) the prototype's form and function with cancer patients/survivors (N=30). The investigators will use Bowen's feasibility model to determine via surveys and interviews: (a) acceptability (satisfaction, perceived appropriateness, perceived positive/negative effects); (b) demand (use of the app, interest or intention to use); (c) practicality (how it makes them feel, ease of use); (d) adaptation (suggestions for modifications to improve performance for cancer patients/survivors); and (e) integration (how can the app be integrated into the cancer "system") Feasibility benchmarks: \>80% of cancer patients/survivors will accept the prototype, demand the prototype for themselves and other cancer patients/survivors, and find it practical. Data from Aim 3 will guide refinement of the prototype to be tested in a fully powered RCT to establish long term engagement (Phase 2). This work will result in an evidence based, cancer-specific meditation app through a commercial platform that can be scaled and sold at discounted costs to clinic providers and directly to patients (SHARE; Phase 3).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2022

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2022

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 17, 2022

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 14, 2022

Completed
Last Updated

July 14, 2022

Status Verified

May 1, 2022

Enrollment Period

12 months

First QC Date

March 17, 2022

Last Update Submit

July 12, 2022

Conditions

Outcome Measures

Primary Outcomes (31)

  • Aim 1: Feasibility: Acceptability as assessed with focus groups

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions asked at one week of use of the current Calm platform

  • Feasibility: Demand as assessed with focus groups

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions asked at one week of use of the current Calm platform

  • Aim 1: Feasibility: Practicality as assessed with focus groups

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions asked at one week of use of the current Calm platform

  • Aim 1: Feasibility: Adaptation as assessed with focus groups

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions asked at one week of use of the current Calm platform

  • Aim 1: Feasibility: Integration as assessed with focus groups

    Integration is defined as Integration degree of execution, amount and type of resources needed to implement, factors affecting ease of implementation according to Bowen and colleagues feasibility criteria.

    Questions asked at one week of use of the current Calm platform

  • Aim 3: Feasibility: Acceptability as assessed with survey

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 1

  • Aim 3: Feasibility: Acceptability as assessed with survey

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 2

  • Aim 3: Feasibility: Acceptability as assessed with survey

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 3

  • Aim 3: Feasibility: Acceptability as assessed with survey

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 4

  • Aim 3: Feasibility: Acceptability as assessed with survey

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) satisfaction survey

  • Aim 3: Feasibility: Acceptability as assessed with interview

    Acceptability is defined as satisfaction, intent to continue to use, perceived appropriateness according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) structured interview

  • Aim 3: Feasibility: Demand as assessed with survey

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 1

  • Aim 3: Feasibility: Demand as assessed with survey

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 2

  • Aim 3: Feasibility: Demand as assessed with survey

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 3

  • Aim 3: Feasibility: Demand as assessed with survey

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 4

  • Aim 3: Feasibility: Demand as assessed with survey

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) survey

  • Aim 3: Feasibility: Demand as assessed with interview

    Demand is defined as actual use, expressed interest or intention to use, perceived demand according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) structured interview

  • Aim 3: Feasibility: Demand captured via Calm-provided data

    Calm will track weekly minutes of meditation participation for each participant.

    Calm-provided data capturing meditation participation at post-intervention (week 4)

  • Aim 3: Feasibility: Practicality as assessed with survey

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 1

  • Aim 3: Feasibility: Practicality as assessed with survey

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 2

  • Aim 3: Feasibility: Practicality as assessed with survey

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 3

  • Aim 3: Feasibility: Practicality as assessed with survey

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 4

  • Aim 3: Feasibility: Practicality as assessed with survey

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) survey

  • Aim 3: Feasibility: Practicality as assessed with interview

    Practicality is defined as ability of participants to carry out intervention activities, efficiency/speed/quality of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) structured interview

  • Aim 3: Feasibility: Adaptation as assessed with survey

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a weekly satisfaction survey (week 1 to week 4)

  • Aim 3: Feasibility: Adaptation as assessed with survey

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 1

  • Aim 3: Feasibility: Adaptation as assessed with survey

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 2

  • Aim 3: Feasibility: Adaptation as assessed with survey

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 3

  • Aim 3: Feasibility: Adaptation as assessed with survey

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a satisfaction survey after week 4

  • Aim 3: Feasibility: Adaptation as assessed with interview

    Adoption is defined as how to promote improvement according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) structured interview

  • Aim 3: Feasibility: Integration as assessed with survey

    Integration is defined as Integration degree of execution, amount and type of resources needed to implement, factors affecting ease of implementation according to Bowen and colleagues feasibility criteria.

    Questions will be asked with a post-intervention (week 4) survey

Study Arms (3)

Calm Meditation Smartphone App Feedback (Aim 1)

OTHER

Advisory committee members will be asked to use the current Calm meditation app platform for a full week and to keep an informal journal prior to participating in focus groups in which they will provide feedback about the app.

Other: Calm Meditation Smartphone App Feedback

Cancer-Specific Meditation App Prototype Design (Aim 2)

OTHER

Findings from Aim 1 will inform the development of a cancer-specific meditation app prototype to be tested in Aim 3.

Other: Cancer-Specific Meditation App Prototype Design

Cancer-Specific Meditation App Prototype (Aim 3)

OTHER

Recruited cancer patients/survivors will be asked to beta-test the cancer-specific app prototype for four weeks. The prototype will be developed in Aim 2 and informed by qualitative findings of Aim 1.

Device: Cancer-Specific Meditation App Prototype

Interventions

Advisory committee members will be asked to use the current Calm meditation app platform for a full week and to keep an informal journal prior to participating in focus groups in which they will provide feedback about the app.

Calm Meditation Smartphone App Feedback (Aim 1)

Findings from Aim 1 will inform the development of a cancer-specific meditation app prototype to be tested in Aim 3.

Cancer-Specific Meditation App Prototype Design (Aim 2)

Recruited cancer patients/survivors will be asked to beta-test the cancer-specific app prototype for four weeks. The prototype will be developed in Aim 2 and informed by qualitative findings of Aim 1.

Cancer-Specific Meditation App Prototype (Aim 3)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Interested cancer patients/survivors (Aim 3) will be asked to complete an eligibility survey via a REDCap survey link. Eligibility criteria is as follows: Patients/survivors will be eligible if they are: * at least 18 years of age * able to read and understand English * identify as a cancer patient (i.e., currently receiving treatment) or a survivor (i.e., prior patient no longer receiving treatment) * willing to download the cancer-specific app prototype to their phone

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Calm, Inc.

San Francisco, California, 94108, United States

Location

Related Publications (1)

  • Huberty J, Bhuiyan N, Puzia M, Joeman L, Larkey L, Mesa R. Meditation Mobile App Developed for Patients With and Survivors of Cancer: Feasibility Randomized Controlled Trial. JMIR Cancer. 2022 Nov 23;8(4):e39228. doi: 10.2196/39228.

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: This study consists of multiple phases/aims, but within each phase/aim (excluding Aim 2 as this is just app development), there is a single group assignment. The intervention model layout described herein was the most appropriate method to describe each of the involved phases and steps.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2022

First Posted

July 14, 2022

Study Start

March 1, 2021

Primary Completion

February 28, 2022

Study Completion

March 15, 2022

Last Updated

July 14, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations